Cassava Sciences INC (FLNA) — 10-Q Filings

10-Q Filings (6)

• Cassava Sciences Swings to $78.4M Loss Amid R&D Cuts — Nov 12, 2025 Risk: high
  Cassava Sciences Inc. (FLNA) reported a significant net loss of $78.434 million for the nine months ended September 30, 2025, a substantial decline from a net i
• Cassava Sciences Swings to $67.6M Loss Amid R&D Cuts — Aug 14, 2025 Risk: high
  Cassava Sciences, Inc. reported a significant net loss of $67.6 million for the six months ended June 30, 2025, a substantial decline from the net income of $31
• Cassava Sciences Q1 2025: Assets Surge, Net Loss Widens — May 8, 2025 Risk: high
  Cassava Sciences Inc. reported its first quarter 2025 results, ending March 31, 2025. The company's financial statements show minimal revenue, with $0.001 milli
• Cassava Sciences Reports $0 Revenue, Increased Expenses — Nov 7, 2024 Risk: high
  Cassava Sciences Inc. filed its 10-Q for the period ending September 30, 2024. The company reported $0 in revenue for the three and nine months ended September
• Cassava Sciences Q2 2024: Cash Up, Equity Down — Aug 8, 2024 Risk: medium
  Cassava Sciences Inc. reported its Q2 2024 results, ending June 30, 2024. The company's financial statements show significant cash and cash equivalents, with $1
• Cassava Sciences Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  CASSAVA SCIENCES INC (FLNA) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Cassava Sciences Inc. reported $0 in revenue for the quarter ended Mar

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX